Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Phase 2 Clinical Trial Data The landmark Phase 2 trial of retatrutide in obesity was a 48-week, randomized, double-blind, placebo-controlled study published in The New England Journal of Medicine in 2023
Severe Gastrointestinal Disease Those with severe gastrointestinal diseases or disorders may need to exercise caution or explore alternative treatment options, as semaglutide could affect the digestive system
176 ZhangY
My skin is literally GLOWING
doi: 10.1027/1015-5759.20.1.39 65 MinnockPKirwanJBresnihanB
US$ 29.74
US$ 26.42
US$ 20.75
US$ 23.61
US$ 20.30
US$ 29.74
